[Treatment of staphylococcal sepsis with antistaphylococcal plasma in patients subjected to surgery for heart defects].
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to A I Gusev.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
This paper presents a critical review of off-line and on-line coupling of matrix-assisted laser desorption/ionization (MALDI) mass spectrometry to liquid column separations (e.g. HPLC, GPC and CE) and planar separations (e.g. PAGE and TLC). Off-line MALDI analysis of fractions collected from HPLC, GPC and CE or spots scraped and extracted from TLC and PAGE has already become a routine practice for many laboratories. MALDI has also been used to obtain mass spectra directly from TLC plates and PAGE. The direct analysis methods range from dot-blotted samples to two-dimensional scanning of the entire gels/plates. Various combinations of on-line coupling of MALDI with column separations are also reviewed. The review discusses the strengths and limitations associated with different off-line and on-line coupling approaches.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Commercial polyclonal IRMA-AFP kit is manufactured by Radiopreparat in Tashkent since 1986. The kit has a range of 0 to 320 ng/ml. This report includes the data on AFP measurements in the sera of cancer patients, particularly at the lower part of the calibration curve. Within run precision studies yielded a CV of 7.7% at the 4.3-54.0 ng/ml interval. Between run precision was 8.6% at the 3.3-56.0 ng/ml interval. The recovery of AFP in the presence of matrix effects of 9 sera was 98% for mixtures at the 9.1-60.8 ng/ml range. The assay sensitivity was 0.6 ng/ml. In donor blood samples the AFP levels did not exceed 4 ng/ml.